Skip to content
Star Health Insurance logo

Star Health Insurance

Star Health & Allied Insurance Company Ltd

STARHEALTH NSE
₹530.50 No trade today
P/E
36.99
View as Markdown
MCP
Close 4 Nov 2026 ₹530.50 +43.80 +9.00% 1Y
Start ₹486.70

Key Fundamentals

SmallcapInsuranceFinancial Services

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
9.69%
Debt to Equity
0.06
EPS (TTM)
₹14.34
Book Value
₹177.29
Market Cap
—
P/E (TTM)
36.99
P/B
2.99
ROE
7.61%
Dividend Yield
0.00%
EBITDA
₹834 Cr
52W High
₹624.90
52W Low
₹416.55
Volume
0

Peer Comparison

Financial Services › Insurance › General Insurance

Star Health Insurance peer comparison
ICICI Lombard General Insurance
₹1,596.3031.17₹80,888 Cr4.240.44%16.60%21.90%₹29,038 Cr₹2,555 Cr
GIC of India
₹323.856.40₹56,281 Cr0.774.15%14.60%17.40%₹52,763 Cr₹8,877 Cr
Star Health Insurance (this company)
₹530.5036.99₹30,850 Cr2.990.00%7.61%9.69%₹19,114 Cr₹844 Cr
New India Assurance Company
₹160.4534.28₹26,368 Cr0.940.96%4.92%4.29%₹49,962 Cr₹776 Cr
Go Digit General Insurance
₹257.1548.25₹24,008 Cr5.100.00%12.20%13.10%₹10,196 Cr₹492 Cr
Niva Bupa Health Insurance Company
₹77.1481.20₹14,080 Cr3.770.00%3.46%3.15%₹7,907 Cr₹174 Cr
Median 6 companies₹290.5035.64₹28,609 Cr3.380.22%9.91%11.40%₹24,076 Cr₹810 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

42 Weak

Data confidence 97/100

Category scores

Quality
47
Average
Returns, margins, earnings quality 22% weight
Valuation
45
Weak
Cheap vs sector & own history 24% weight
Growth
41
Weak
Sales & profit trajectory 9% weight
Financial Health
33
Poor
Solvency, leverage, coverage 9% weight
Momentum
47
Average
Trend strength, vol-adjusted 12% weight
Ownership
34
Poor
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

3
  • Stock is trading at 4.19 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 10.2% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish874
OscillatorsBearish270
Moving AveragesStrong Bearish604

Key readings

RSI (14)
45.59
Neutral
MACD (12,26,9)
−7.88
Bearish
SMA (50)
551.19
Bearish
SMA (200)
524.15
Bullish

As of

Analyst Rating

Based on 19 analysts
BUY84%

16 of 19 analysts rate Buy, 2 Hold, 1 Sell.

As of

BUY
16
84%
HOLD
2
11%
SELL
1
5%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+27.30%
5Y+28.69%
3Y+13.80%
1Y+10.71%
TTM+11.35%

Net profit

Net profit growth by window
10Y+15.06%
5YTurned to profit
3Y−3.46%
1Y−13.78%
TTM+10.33%

Operating cash flow

Operating cash flow growth by window
10Y—
5Y+16.05%
3Y+13.65%
1Y+35.82%
TTM—

10Y: The statements do not go back far enough for this window.

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−5.16 pp
5Y+32.28 pp
3Y−2.60 pp
1Y−1.10 pp
TTM+0.09 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹2,012 Cr
Mar 2018₹2,888 Cr
Mar 2019₹3,775 Cr
Mar 2020₹4,987 Cr
Mar 2021₹5,050 Cr
Mar 2022₹10,602 Cr
Mar 2023₹12,096 Cr
Mar 2024₹14,021 Cr
Mar 2025₹16,101 Cr
Mar 2026₹17,825 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹118 Cr
Mar 2018₹170 Cr
Mar 2019₹128 Cr
Mar 2020₹268 Cr
Mar 2021−₹1,086 Cr
Mar 2022−₹1,041 Cr
Mar 2023₹619 Cr
Mar 2024₹845 Cr
Mar 2025₹646 Cr
Mar 2026₹557 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EPS
₹5.11 +13.6% vs Sep 26
Reported High Mean Low

AI News Digest

9h ago

TL;DR: Limited news flow for Star Health this period, with only a routine analyst meeting disclosure. No material positives or negatives emerged. Investor engagement continues with scheduled institutional meetings, but the lack of operational or financial updates leaves the near-term outlook data-light.

Neutral 1
  • Analyst meetings scheduled Nov 6 Nov 02

    Star Health scheduled one-on-one, in-person analyst meetings in Mumbai on November 6, 2026 with Bandhan AMC and 3P Investment Managers. Disclosure was filed on November 2, 2026 under SEBI regulations.

Quarterly Results

₹ Cr
STARHEALTH quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
3,293
3,461
3,578
3,688
3,816
4,058
4,146
4,081
4,880
4,378
4,566
4,648
5,522
Expenses
2,909
3,296
3,191
3,502
3,391
3,912
3,861
4,089
4,292
4,303
4,395
4,500
4,773
Operating Profit
384
165
387
186
425
147
285
−7
588
75
172
148
749
OPM %
12%
4.8%
11%
5%
11%
3.6%
7%
−0.2%
12%
1.7%
3.8%
3.2%
14%
Other Income
0
2
1
3
1
2
2
6
0
3
2
4
−8
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
384
167
388
190
426
149
287
−1
588
78
173
151
742
Tax %
25%
25%
25%
25%
25%
25%
25%
−159%
25%
29%
26%
26%
26%
Net Profit
288
125
290
142
319
111
215
1
438
55
128
111
550
EPS (₹)
4.95
2.15
4.95
2.43
5.45
1.89
3.66
0.01
7.45
0.93
2.18
1.89
9.34

Profit & Loss

₹ Cr
STARHEALTH profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1,069
1,595
2,012
2,888
3,775
4,987
5,050
10,602
12,096
14,021
16,101
17,825
19,114
Expenses
1,189
1,439
1,871
2,673
3,565
4,544
6,447
11,962
11,223
12,840
15,180
17,001
17,971
Operating Profit
−120
156
141
215
210
443
−1,397
−1,360
873
1,182
921
824
1,143
OPM %
−11%
10%
7%
7%
6%
9%
−28%
−13%
7%
8%
6%
4.6%
6%
Other Income
0
0
0
0
0
0
−3
7
5
6
12
9
1
Interest
1
2
3
20
0
0
0
0
0
0
0
0
0
Depreciation
19
18
20
23
28
29
46
43
52
59
71
79
0
PBT
−140
137
118
171
182
413
−1,446
−1,397
826
1,129
861
754
1,144
Tax %
0%
0%
0%
1%
30%
35%
−25%
−25%
25%
25%
25%
26%
—
Net Profit
−140
137
118
170
128
268
−1,086
−1,041
619
845
646
557
844
EPS (₹)
−3.87
3.53
2.59
3.73
2.81
5.46
−19.81
−18.08
10.63
14.44
10.99
9.47
14.34
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
STARHEALTH balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
362
387
456
456
456
491
548
576
582
585
588
588
Reserves
−220
−27
334
504
773
1,153
2,947
4,045
4,862
5,799
6,471
6,987
Borrowings
0
0
0
250
250
250
250
720
470
470
470
470
Other Liabilities
954
1,012
1,423
2,138
3,394
4,233
6,756
8,174
9,313
10,914
13,255
16,019
Total Liabilities
1,096
1,372
2,213
3,347
4,872
6,127
10,501
13,514
15,226
17,768
20,785
24,064
Fixed Assets
46
62
77
92
85
90
183
113
217
159
357
404
CWIP
12
3
7
5
13
12
19
4
10
16
24
9
Investments
502
807
1,428
2,165
3,030
4,290
6,733
11,373
13,276
15,491
17,703
19,780
Other Assets
535
500
700
1,085
1,744
1,735
3,565
2,024
1,723
2,102
2,701
3,871
Total Assets
1,096
1,372
2,213
3,347
4,872
6,127
10,501
13,514
15,226
17,768
20,785
24,064

Cash Flow

₹ Cr
STARHEALTH cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
—
321
557
776
647
890
56
1,276
1,310
1,379
1,873
Investing
—
—
−497
−663
−731
−1,006
−2,418
−3,786
−1,097
−1,177
−1,151
−1,067
Financing
—
—
310
249
333
122
2,613
2,509
−268
23
−4
−31
Net Cash Flow
—
—
134
143
379
−237
1,086
−1,221
−89
156
224
775
Free Cash Flow
—
—
283
521
746
614
844
−7
1,229
1,187
1,297
1,797
CFO/EBITDA
—
—
228
260
397
168
−70
−4
145
119
170
250

Ratios

STARHEALTH financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
0
0
0
0
0
0
0
0
0
0
0
0
Cash Conversion Cycle
0
0
0
0
0
0
0
0
0
0
0
0
Working Capital Days
−255
−179
−191
−196
−260
−238
−397
−258
−255
−249
−261
−286
ROCE %
—
55%
21%
19%
14%
25%
−51%
−31%
15%
18%
12%
10%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Star Health Insurance insights

36 extracted metrics across FY15–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 58.00%
  • DIIs 18.77%
  • FIIs 15.85%
  • Public 4.39%
  • Others 2.98%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Star Health Insurance

What does Star Health & Allied Insurance Company Ltd do?
Star Health & Allied Insurance Ltd (Star) is India’s first Standalone Health Insurance provider and is the largest private health insurer in India with a market share of 15.8% in the Indian health insurance market in FY21 with leadership in the attractive retail health segment.
Where is Star Health & Allied Insurance Company Ltd (STARHEALTH) listed?
Star Health & Allied Insurance Company Ltd trades as STARHEALTH on the NSE and under code 543412 on the BSE.
Which sector does Star Health & Allied Insurance Company Ltd belong to?
Star Health & Allied Insurance Company Ltd is classified under the Insurance sector, in the General Insurance industry.
What is the PE ratio of Star Health & Allied Insurance Company Ltd?
Star Health & Allied Insurance Company Ltd trades at a PE ratio of 36.99 as of 4 Nov 2026, on earnings per share of ₹14.34, against a book value of ₹177.29 per share.
What is the 52-week high and low of Star Health & Allied Insurance Company Ltd?
Over the last 52 weeks Star Health & Allied Insurance Company Ltd has traded between ₹416.55 and ₹624.9 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Star Health & Allied Insurance Company Ltd?
Star Health & Allied Insurance Company Ltd reported a return on equity of 7.61%. Its debt-to-equity ratio is 0.06.

Company Information

Star Health & Allied Insurance Ltd (Star) is India’s first Standalone Health Insurance provider and is the largest private health insurer in India with a market share of 15.8% in the Indian health insurance market in FY21 with leadership in the attractive retail health segment.

Website starhealth.in
Listed 10 Dec 2021
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/STARHEALTH.md for Star Health & Allied Insurance Company Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Insurance stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month